Profile of circulating lymphocyte subsets in patients with atrial fibrillation: implications for the comorbidity of hypertension

Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024; 45: 3314-414.

Google Scholar

Grune J, Yamazoe M, Nahrendorf M. Electroimmunology and cardiac arrhythmia. Nat Rev Cardiol 2021; 18: 547-64.

Google Scholar

Yue H, Gu J, Zhao X, et al. Role of the interleukin-17 pathway in the pathogenesis of atrial fibrillation associated with inflammation. Arch Med Sci 2021; 17: 262-5.

Google Scholar

Yamashita T, Sekiguchi A, Iwasaki Y, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 2010; 74: 262-70.

Google Scholar

Yamashita T, Sekiguchi A, Suzuki S, et al. Enlargement of the left atrium is associated with increased infiltration of immune cells in patients with atrial fibrillation who had undergone surgery. J Arrhythm 2015; 31: 78-82.

Google Scholar

Sulzgruber P, Koller L, Winter M, et al. The impact of CD4+CD28null T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure. Thromb Haemost 2017; 117: 349-56.

Google Scholar

Drummond GR, Vinh A, Guzik TJ, Sobey CG. Immune mechanisms of hypertension. Nat Rev Immunol 2019; 19: 517-32.

Google Scholar

Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-60.

Google Scholar

Mattson DL, Lund H, Guo C, Rudemiller N, Geurts AM, Jacob H. Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am J Physiol Regul Integr Comp Physiol 2013; 304: R407-14.

Google Scholar

10.

Rudemiller N, Lund H, Jacob HJ, Geurts AM, Mattson DL. CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension 2014; 63: 559-64.

Google Scholar

11.

Daniel AK, Tlili B, Melissa WL, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 2011; 59: 324-30.

Google Scholar

12.

Masato K, Yoshitaka H, Takuya K, Kenji S. Decreased proportion of Foxp3+ CD4+ regulatory T cells contributes to the development of hypertension in genetically hypertensive rats. J Hypertens 2015; 33: 773-83.

Google Scholar

13.

Imiela AM, Mikołajczyk TP, Siedliński M, et al. Th17/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension. Pol Arch Intern Med 2022; 132: 16171.

Google Scholar

14.

Gackowska L, Michalkiewicz J, Helmin-Basa A, et al. Regulatory T-cell subset distribution in children with primary hypertension is associated with hypertension severity and hypertensive target organ damage. J Hypertens 2020; 38: 692-700.

Google Scholar

15.

Madhur MS, Lob HE, McCann LA, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55: 500-7.

Google Scholar

16.

Trott DW, Thabet SR, Kirabo A, et al. Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension 2014; 64: 1108-15.

Google Scholar

17.

Liu Y, Rafferty TM, Rhee SW, et al. CD8(+) T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension. Nat Commun 2017; 8: 14037.

Google Scholar

Submit your paper

eISSN:	1896-9151
ISSN:	1734-1922